Physician

Karl Coblenz Bentley, M.D.

According to 2025 Medicare claims, Karl Bentley, M.D. (NPI: 1912192816) practices ophthalmology in the McAllen-Edinburg-Mission, TX market, with the plurality of this provider's patient population coming from Hidalgo, TX. This provider's primary affiliated billing organization is THURMOND EYE ASSOCIATES, PLLC (NPI: 1629023460; TIN: 741695861) and primary practice location at 78503-9998. Bentley is affiliated with the Health Partners for the Elderly LLC (ACO ID: D0084), participating under the REACH model.

Bentley's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 818 traditional Medicare patients, billed 2,120 HCPCS/CPT codes, and received $209,956 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 8,812 prescription claims across 2,431 beneficiaries totaling $702,257 in drug costs, led by Xiidra (Lifitegrast). DME data shows 11 claims. Open Payments data shows 15 records totaling $379. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $428,851 to $209,956. In contrast, Part D prescription costs have risen steadily, from $571,429 to $702,257. For DME billing, this smaller-volume category changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,728	4,072	$428,851
2016	1,672	3,903	$426,900
2017	1,527	3,932	$430,238
2018	1,475	3,954	$456,068
2019	1,451	3,836	$422,655
2020	1,232	3,037	$323,044
2021	1,192	2,891	$317,111
2022	1,163	2,688	$277,408
2023	994	2,238	$229,754
2024	818	2,120	$209,956

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,387	5,585	$571,429
2016	1,528	6,095	$607,350
2017	1,523	6,013	$560,001
2018	1,719	6,368	$685,501
2019	1,932	6,484	$790,048
2020	1,890	6,930	$802,649
2021	1,915	6,585	$829,504
2022	2,230	7,989	$981,911
2023	2,444	8,989	$1,005,186
2024	2,431	8,812	$702,257

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	234	234	$11,256
2016	156	156	$6,932
2017	102	102	$5,477
2018	122	122	$6,264
2019	74	75	$3,877
2020	46	47	$2,697
2021	43	44	$2,450
2022	28	28	$1,744
2023	13	13	$1,047
2024	11	11	$411

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	314	336	$91
92014	Established patient complete exam of visual system	288	309	$70
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	119	145	$66
92083	Exam of visual field with extended testing	124	127	$44
92133	Imaging of optic nerve	170	177	$25

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xiidra	Lifitegrast	70	5,340	$114,354
Restasis	Cyclosporine	84	5,580	$109,644
Lumigan	Bimatoprost	125	7,439	$66,905
Latanoprost	Latanoprost	3,769	238,862	$56,966
Cyclosporine	Cyclosporine	56	4,140	$52,970

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
V2020	Frames, purchases	N	11	11	$411

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	15	$379	RxSight Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Karl Coblenz Bentley, M.D.?

Tedicare shows public-source Medicare data for Karl Coblenz Bentley, M.D. (NPI 1912192816), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Karl Coblenz Bentley, M.D. have ACO affiliation data?

Karl Coblenz Bentley, M.D. is shown with ACO affiliation data for Health Partners for the Elderly LLC (REACH, ACO ID D0084).

What billing organization is linked to Karl Coblenz Bentley, M.D.?

Karl Coblenz Bentley, M.D. is linked to THURMOND EYE ASSOCIATES, PLLC (billing NPI 1629023460) in the available physician profile data.

Does Karl Coblenz Bentley, M.D. have Open Payments data?

Karl Coblenz Bentley, M.D. has 15 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.